(Q43573213)

24 November 2017

Long-term effects of ceftriaxone treatment on intraocular Lyme borreliosis (English)

1 reference

24 November 2017

0 references

1 reference

M S Suttorp-Schulten

1

1 reference

24 November 2017

H Kuiper

2

1 reference

24 November 2017

A Kijlstra

3

1 reference

24 November 2017

A P van Dam

4

1 reference

24 November 2017

A Rothova

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

American Journal of Ophthalmology

24 November 2017

1 reference

24 November 2017

116

1 reference

24 November 2017

5

1 reference

24 November 2017

571-575

1 reference

Nervous system Lyme borreliosis--revisited [corrected; erratum to be published]

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Lyme disease: neurologic and ophthalmic manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Spiderweb vitritis in Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

The expanding ophthalmologic spectrum of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Prevention of Lyme disease after tick bites. A cost-effectiveness analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Ocular Lyme disease: case report and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Bilateral keratitis in Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Neuro-ophthalmologic manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Intermediate uveitis and Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Neuro-ocular Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

1 reference

7 January 2021

Lyme disease: recommendations for diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Treatment of late Lyme borreliosis--randomised comparison of ceftriaxone and penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Ceftriaxone as effective therapy in refractory Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

1 reference

7 January 2021

International Uveitis Study Group recommendations for the evaluation of intraocular inflammatory disease

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

Signs and symptoms of uveitis. II. Classification of the posterior manifestations of uveitis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9394%2814%2973198-8

7 January 2021

10.1016/S0002-9394(14)73198-8

Identifiers

DOI

0 references

1 reference